IRRIV International Renal Research Institute Vicenza

 

38th Vicenza Course on AKI and CRRT
V

Interventional Clinical Trial: Does Extracorporeal CO2 Improve Renal Function of Patients with Acute Respiratory Distress and AKI? How Does COVID-19 Play a Factor?

By 38th Vicenza Course on AKI and CRRT FEATURING V. Marco Ranieri
By 38th Vicenza Course on AKI and CRRT FEATURING V. Marco Ranieri
85 views
February 3, 2021
0 Comments
Login to view comments. Click here to Login
38th Vicenza Course on AKI and CRRT
15:47
38th Vicenza Course on AKI and CRRT

Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Biomarker in …

Feat. C. Albert, K. Doi
14:26
38th Vicenza Course on AKI and CRRT

Septic AKI: Can Dialysis Membranes Be Used as a Therapeutic Approach?

Feat. V. Cantaluppi
11:50
38th Vicenza Course on AKI and CRRT

Procoagulant State with COVID-19: Do We Need to Adapt Anticoagulatio…

Feat. A. G. Schneider
12:54
38th Vicenza Course on AKI and CRRT

Citrate vs. Heparin Anticoagulation in CRRT: What to Recommend?

Feat. D. Khadzhynov
13:30
38th Vicenza Course on AKI and CRRT

The Clinical Path for CRRT NICU Adoption: How To Know When the Risks…

Feat. S. Goldstein
18:52
38th Vicenza Course on AKI and CRRT

How CARPEDIEM Helps Increase Adoption of Continuous Renal Replacemen…

Feat. E. Vidal
14:36
38th Vicenza Course on AKI and CRRT

Polymyxin B HemoPerfusion Therapy for Endotoxemia: Does it Have a Ro…

Feat. S. Lucio Cutuli
15:54
38th Vicenza Course on AKI and CRRT

Cytokine Removal Therapy: What Is Its Role in The Treatment of Sepsi…

Feat. F. Sanchez Moran
06:15
38th Vicenza Course on AKI and CRRT

79 y/o Male with Bacterial Septic Shock Treated With Renal Replaceme…

Feat. F. Sanchez Moran
12:24
38th Vicenza Course on AKI and CRRT

Extra-Corporeal Blood Purification in Critically Ill Septic Patients…

Feat. A. Armaganidis
17:40
38th Vicenza Course on AKI and CRRT

Endotoxic Shock and COVID-19: What Is The Role of Polymyxin B Hemope…

Feat. S. De Rosa
17:47
38th Vicenza Course on AKI and CRRT

What Is the Use of Biomarkers for the Management of AKI In the Criti…

Feat. L. G Forni
21:48
38th Vicenza Course on AKI and CRRT

Can Biomarkers Be Utilized in the Management of Cardiac Surgery Asso…

Feat. D. T. Engelman
11:47
38th Vicenza Course on AKI and CRRT

Why Should We Utilize Continuous Venovenous Hemodialysis as Modality…

Feat. A. G. Schneider
12:42
38th Vicenza Course on AKI and CRRT

Interventional Clinical Trial: Does Extracorporeal CO2 Improve Renal…

Feat. V. Marco Ranieri
08:45
38th Vicenza Course on AKI and CRRT

The Unknown Relevance of Endotoxemia and Patients with COVID-19: Doe…

Feat. D. Yamane
11:33
38th Vicenza Course on AKI and CRRT

Endotoxemia and COVID-19 Experiences From the Stony Brook University…

Feat. S. Mallipattu
17:45
38th Vicenza Course on AKI and CRRT

Comparing AKI in Sepsis and AKI in Patients With COVID-19: What Are …

Feat. P. Pickkers
17:36
38th Vicenza Course on AKI and CRRT

Overview of The World Registry for RRT: Can We Manipulate the Immune…

Feat. S. Romagnoli